Title:
Team Grant: Transnational Cardiovascular Research Projects
Agreement Value:
$290,250.00
Agreement Date:
May 1, 2021 - Apr 30, 2024
Description:
The specific objectives of this funding opportunity are to:
• Foster transnational cooperation of European countries and beyond, and to coordinate research efforts and funding programs of the ERA-CVD partner countries with Canada;
• Promote co-operation and interchange for Canadian Early and Mid-Career Researchers and enable international collaboration and new consortia establishment in cardiovascular research;
• Enable capacity building and empowering of Canadian Early and Mid-Career Scientists by providing an opportunity to independently develop and perform internationally linked highly innovative research projects; and
• Add value in funding the collaboration over individual projects by sharing of resources (e.g., models, databases, diagnosis etc.), harmonization of data, sharing of specific know-how and/or innovative technologies.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Ottawa, Ontario, CA K1Y 4W7
Reference Number:
236-2021-2022-Q1-00584
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Rayner, Katey
Research Organization:
Ottawa Heart Institute Research Corporation (Ontario)
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.